News & Events

Display # 
Title Published Date
Lipopharma awarded a grant for SMEs to carry out innovative research 26 July 2018
Lipopharma announces IND approval by the FDA to proceed with a PhI paediatric trial assessing 2OHOA in children with advanced brain and other solid tumours 29 May 2018
Lipopharma awarded a 6,15M€ grant by the H2020 Programme to conduct a PIIb trial with 2OHOA in patients with newly-diagnosed glioblastoma 21 January 2018
Final results of the MIN-001-1203 study with 2OHOA in oncology presented at ASCO 2017 annual meeting in Chicago 05 June 2017
Dr Rosselló awarded a Felip Bauçà grant 12 December 2016
Lipopharma closes patient recruitment in its first clinical study with 2OHOA in cancer 01 August 2016
Lipopharma initiates recruitment in expansion cohorts of clinical study with 2OHOA in cancer 23 November 2015
Lipopharma presents latest results of 2OHOA study in cancer at Bio-Europe 2015 17 November 2015
Updated results of Minerval study in cancer presented at ASCO 2015 30 May 2015
Key patent for 2OHOA in oncology granted in the United States by the USPTO 07 April 2015
Lipopharma presents the last results of the clinical trial with 2OHOA at BIO-Europe 2014 04 November 2014
Lipopharma joins the “Junior Lab” initiative launched by the Biotechnological and Biomedical Cluster of the Balearic Islands 30 October 2014
Her Majesty the Queen Sofia of Spain pays a private visit to the research group lead by Dr escriba and Dr. Busquets at the UIB 25 August 2014
Prof. G.L. Nicolson and Prof. R.M. Epand join Lipopharma's SAB 16 June 2014
Lipopharma galardonada con el Premio Onda Cero Mallorca de Ciencia e Investigación 2013 16 December 2013
Lipopharma awarded as one of the best European biotech projects at the EVC 2013 10 December 2013
Lipopharma announces at Biotrinity 2013 the initiation of the first clinical study in cancer with 2OHOA 15 May 2013
Lipopharma presented MLT-based 2OHOA for glioma at Bio-Europe Spring 2013 in Barcelona 13 March 2013
Lipopharma to present at the December's European Venture Summit in Berlin 25 October 2012
2OHOA designated as Orphan Drug in Europe for the treatment of glioma 21 October 2011

Supported by



© 2019 Lipopharma | legal notice Copyright 2011 Lipopharma - News. All Rights Reserved.
Joomla 1.7 templates by hostgator coupon and learn how to make a website